691 Results

People

  1. De Angelis
    De Angelis
  2. Yahalom
    Yahalom
  3. Abrey
    Abrey
  4. Tallman
    Tallman
  5. Zelenetz
    Zelenetz
  6. Moskowitz
    Moskowitz
  7. Berman
    Berman
  8. Steinherz
    Steinherz
  9. Andreeff
    Andreeff
  10. Horwitz
    Horwitz

Groups

  1. Department of Medicine (359)
  2. Center for Hematologic Malignancies (304)
  3. Hematologic Malignancies, Division of (301)
  4. Adult Leukemia (134)
  5. Tow Center for Developmental Oncology (TCDO) (103)
  6. Survivorship Research (102)
  7. Lymphoma (86)
  8. Sloan Kettering Institute Faculty (82)
  9. GSK Faculty (75)
  10. Pediatrics, Department of (75)
  1. "cytarabine"
Formats
  1. Journal Article (637)
  2. Review (20)
  3. Conference Paper (19)
  4. Research Letter (6)
  5. Correspondence (3)
  6. Editorial (2)
  7. Meeting Abstract (2)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (359)
  2. Center for Hematologic Malignancies (304)
  3. Hematologic Malignancies, Division of (301)
  4. Adult Leukemia (134)
  5. Tow Center for Developmental Oncology (TCDO) (103)
  6. Survivorship Research (102)

More Groups

People
  1. Lisa De Angelis (53)
  2. Martin Tallman (42)
  3. Joachim Yahalom (39)
  4. Lauren Abrey (38)
  5. Peter Steinherz (34)
  6. Andrew Zelenetz (33)

More People

Years
  1. 2025 (15)
  2. 2024 (28)
  3. 2023 (17)
  4. 2022 (11)
  5. 2021 (9)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (45)
  2. Blood (41)
  3. Cancer (29)
  4. Leukemia (27)
  5. Bone Marrow Transplantation (25)
  6. Leukemia and Lymphoma (23)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. Nature Publishing Group (67)
  3. American Society of Hematology (52)
  4. Springer (52)
  5. American Society of Clinical Oncology (48)
  6. Lippincott Williams & Wilkins (38)

More Publishers

Results (691)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features
    Correspondence

    Zibara, V.; Sen, F.; Scordo, M.; Falchi, L.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Investigational venetoclax combination therapy in acute myeloid leukemia - A systematic review and meta-analysis
    Research Letter

    Shimony, S.; Rozental, A.; Bewersdorf, J. P.; Goldberg, A. D.; Stein, E. M.; Grimshaw, A. A.; Stone, R. M.; DeAngelo, D. J.; Wolach, O.; Stahl, M.
    Haematologica (2022)

    Fulltext@MSK | Save
  • The cost-effectiveness of axicabtagene ciloleucel as second-line therapy in patients with large B-cell lymphoma in the United States: An economic evaluation of the ZUMA-7 trial
    Journal Article

    Perales, M. A.; Kuruvilla, J.; Snider, J. T.; Vadgama, S.; Blissett, R.; El-Moustaid, F.; Smith, N. J.; Patel, A. R.; Johnston, P. B.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, carmustine, etoposide, and prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: A retrospective single-center study
    Journal Article

    Reiss, S. N.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant
    Journal Article

    Sola, M.; Bhatt, V.; Palazzo, M.; Cavalier, K. E.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D.; Dahi, P. B.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Ibrutinib associated with rituximab-platinum salt-based immunochemotherapy in B-cell lymphomas: Results of a phase 1b-II study of the LYSA group
    Journal Article

    Bonnet, C.; Dupuis, J.; Tilly, H.; Lamy, T.; Fruchart, C.; le Gouill, S.; Thieblemont, C.; Morschhauser, F.; Casasnovas, O.; Bouabdallah, K.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Characteristics and outcome of extranodal NK/T-cell lymphoma in North America: A retrospective multi-institutional experience
    Journal Article

    Bennani, N. N.; Tun, A. M.; Carson, K. R.; Geiger, J. L.; Maeda, L. S.; Savage, K. J.; Rose, J.; Pinter-Brown, L.; Lunning, M. A.; Abramson, J. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Rosai–Dorfman–Destombes disease of the nervous system: A systematic literature review
    Review

    Nasany, R. A.; Reiner, A. S.; Francis, J. H.; Abla, O.; Panageas, K. S.; Diamond, E. L.
    Orphanet Journal of Rare Diseases (2022)

    Fulltext@MSK | Save
  • Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission
    Journal Article

    Shadman, M.; Pasquini, M.; Ahn, K. W.; Chen, Y.; Turtle, C. J.; Hematti, P.; Cohen, J. B.; Khimani, F.; Ganguly, S.; Merryman, R. W.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Prospects in the management of patients with follicular lymphoma beyond first-line therapy
    Journal Article

    Qualls, D.; Salles, G.
    Haematologica (2022)

    Fulltext@MSK | Save